These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 29530725)

  • 1. Movement disorders in multiple sclerosis and neuromyelitis optica: A clinical marker of neurological disability.
    Candeias da Silva C; Bichuetti DB; Azevedo Silva SMC; Ferraz HB; Oliveira EML; Borges V
    Parkinsonism Relat Disord; 2018 Jun; 51():73-78. PubMed ID: 29530725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysphagia in neuromyelitis optica spectrum disorder and multiple sclerosis: A comparison of frequency, severity, and effects on quality of life.
    Afsharzadeh M; Mirmosayyeb O; Vaheb S; Shaygannejad A; Maracy M; Shaygannejad V
    Mult Scler Relat Disord; 2024 Jul; 87():105640. PubMed ID: 38692153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease.
    Zhang Y; Zhang X; Liu D; Wang H; Pan S; Wang D; Chen X
    Neurol Sci; 2016 Nov; 37(11):1823-1829. PubMed ID: 27450097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Movement disorders in multiple sclerosis and other demyelinating diseases.
    Mehanna R; Jankovic J
    J Neurol Sci; 2013 May; 328(1-2):1-8. PubMed ID: 23522528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life of patients with multiple sclerosis and neuromyelitis optica spectrum disorders: Cross-sectional and longitudinal analysis.
    Kim S; Lee EJ; Kim KW; Seo D; Moon S; Kim KK; Lim YM
    Mult Scler Relat Disord; 2022 Feb; 58():103500. PubMed ID: 35032884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxysmal dystonia and neuromyelitis optica.
    Schmidt FR; Costa FH; Silva FM; Maultasch H; Rosso AL; Nicaretta DH; Mattos JP; Novis SA; Alves-Leon SV
    Arq Neuropsiquiatr; 2012 Apr; 70(4):271-2. PubMed ID: 22358312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH; Kwak K; Jeong IH; Hyun JW; Jo HJ; Joung A; Yu ES; Kim JH; Lee SH; Yun S; Joo J; Lee DK; Lee JM; Kim HJ
    Mult Scler; 2016 Dec; 22(14):1850-1858. PubMed ID: 26920380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
    Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
    Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorders by multiparametric quantitative MRI using convolutional neural network.
    Hagiwara A; Otsuka Y; Andica C; Kato S; Yokoyama K; Hori M; Fujita S; Kamagata K; Hattori N; Aoki S
    J Clin Neurosci; 2021 May; 87():55-58. PubMed ID: 33863534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder.
    Pula JH; Kattah JC; Keung B; Wang H; Daily J
    J Neurol Sci; 2014 Oct; 345(1-2):209-12. PubMed ID: 25125046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye movement abnormalities in AQP4-IgG positive neuromyelitis optica spectrum disorder.
    Sun H; Cui S; Gao F; You Q; Li Y; Wang J; Zhang X
    J Neurol Sci; 2018 Jan; 384():91-95. PubMed ID: 29249386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voiding dysfunction in patients with neuromyelitis optica spectrum disorders.
    de Carvalho FL; Gomes CM; Apostolos-Pereira SL; Bessa J; Pinheiro M; Marchiori PE; Bruschini H; Srougi M; Callegaro D
    Neurourol Urodyn; 2016 Jan; 35(1):39-43. PubMed ID: 25212666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric-onset multiple sclerosis in Brazilian patients: Clinical features, treatment response and comparison to pediatric neuromyelitis optica spectrum disorders.
    Fragomeni MO; Bichuetti DB; Oliveira EML
    Mult Scler Relat Disord; 2018 Oct; 25():138-142. PubMed ID: 30075406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resilience and depression/anxiety symptoms in multiple sclerosis and neuromyelitis optica spectrum disorder.
    Nakazawa K; Noda T; Ichikura K; Okamoto T; Takahashi Y; Yamamura T; Nakagome K
    Mult Scler Relat Disord; 2018 Oct; 25():309-315. PubMed ID: 30176401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
    Collongues N; Marignier R; Jacob A; Leite MI; Siva A; Paul F; Zephir H; Akman-Demir G; Elsone L; Jarius S; Papeix C; Mutch K; Saip S; Wildemann B; Kitley J; Karabudak R; Aktas O; Kuscu D; Altintas A; Palace J; Confavreux C; De Seze J
    Mult Scler; 2014 Jul; 20(8):1086-94. PubMed ID: 24323817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy.
    Wang Y; Wu A; Chen X; Zhang L; Lin Y; Sun S; Cai W; Zhang B; Kang Z; Qiu W; Hu X; Lu Z
    BMC Neurol; 2014 Dec; 14():246. PubMed ID: 25526927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Painful tonic spasms and brainstem involvement in a patient with neuromyelitis optica spectrum disorder.
    Roman-Filip C; Ungureanu A; Cernuşcă-Miţaru M
    Neurol Neurochir Pol; 2016; 50(1):55-8. PubMed ID: 26851692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study.
    Kanamori Y; Nakashima I; Takai Y; Nishiyama S; Kuroda H; Takahashi T; Kanaoka-Suzuki C; Misu T; Fujihara K; Itoyama Y
    Neurology; 2011 Aug; 77(7):652-8. PubMed ID: 21813781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and incidence of neuromyelitis optica spectrum disorder and multiple sclerosis in Korea.
    Kim JE; Park SH; Han K; Kim HJ; Shin DW; Kim SM
    Mult Scler; 2020 Dec; 26(14):1837-1844. PubMed ID: 31749401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.